1. Novel prognostic index based on hemoglobin level and platelet count for diffuse large B-cell lymphoma, not otherwise specified in the R-CHOP era
   Shoko Nakayama et al, 2019, Platelets CrossRef
2. Novel prognostic predictor of haemoglobin–platelet index in diffuse large B‐cell lymphoma, not otherwise specified: Anaemia and thrombocytopenia are associated with IL‐6 production in lymphoma cells
   Takahide Taniguchi et al, 2022, British Journal of Haematology CrossRef
3. Utility of a simple prognostic stratification based on platelet counts and serum albumin levels in elderly patients with diffuse large B cell lymphoma
   Yotaro Ochi et al, 2017, Annals of Hematology CrossRef
4. Application of Pharmacometric Analysis in the Design of Clinical Pharmacology Studies for Biosimilar Development
   Peijuan Zhu et al, 2018, The AAPS Journal CrossRef
5. Identification of B‑cell translocation gene 1‑controlled gene networks in diffuse large B‑cell lymphoma: A study based on bioinformatics analysis
   Wei Yan et al, 2019, Oncology Letters CrossRef
6. New prognosis score including absolute lymphocyte/monocyte ratio, red blood cell distribution width and beta‐2 microglobulin in patients with diffuse large B‐cell lymphoma treated with R‐CHOP: Spanish Lymphoma Group Experience (GELTAMO)
   Leyre Bento et al, 2020, British Journal of Haematology CrossRef